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Determining the optimal target blood
pressure after thrombectomy
High or low?
The management of patients with acute ischemic
stroke has changed dramatically with modern
mechanical thrombectomy (MT) techniques and
improved patient selection using CT angiography.1
Although the benefit of early recanalization in large
vessel occlusion (LVO) seems clear, the optimal peri-
procedural management remains uncertain. Unre-
solved issues include the method of analgesia and
sedation, reversal and application of adjunctive peri-
procedural anticoagulation, glycemic control, ventila-
tory management, and perhaps most important,
blood pressure (BP) control.
Current guidelines inadequately address BP man-
agement after MT, given the lack of randomized con-
trolled trials.2,3 Observational studies indicate higher
mortality and greater frequency of neurologic deteri-
oration with extremely high or low admission BP, as
compared to when BP falls in a middle range or
“sweet spot.”4 Retrospective analyses have linked
larger anesthesia-related reductions in BP during the
MT procedure with poor outcome, whether general
anesthesia5,6 or conscious sedation.7 Another study
found an association between intraprocedural
anesthesia-related hypotension treated with IV nor-
epinephrine and poor functional outcome after MT.8
Data regarding BP management after MT are even
more scant.
In this issue of Neurology®, Goyal et al.9 report the
relationship of maximum BP levels after MT and
long-term functional independence in 217 patients
with acute ischemic stroke due to LVO in the anterior
or posterior circulation. All patients underwent
mechanical recanalization through a combination of
stent retriever deployment with or without distal aspi-
ration, first pass direct aspiration, or angioplasty and
stenting within 8 hours of symptom onset. Sixty-five
percent of patients received systemic thrombolysis
prior to intervention. All data were collected prospec-
tively, including hourly BP values.
Sixty-five percent of patients achieved complete
recanalization (Thrombolysis in Cerebral Infarction
[TICI] score of 2B or 3). The authors evaluated 3
groups according to the BP goal and thrombolysis
status: (1) permissive hypertension (220/120 mm
Hg without systemic thrombolysis or ,180/90 mm
Hg with systemic thrombolysis); (2) moderate BP
control (,160/90 mm Hg); and (3) intensive BP
control (,140/90 mmHg) based on American Heart
Association guidelines,2 institutional practice stand-
ards, and physician preference. They constructed
multivariable models to determine the relationship
between minimum, maximum, and mean systolic
and diastolic BP levels during the first 24 hours after
MT and functional independence (defined as a mod-
ified Rankin Scale score of 0–2) and mortality at 3
months.
Overall, 45% of patients achieved functional inde-
pendence at 3 months, 26% died, and 6.5% experi-
enced a symptomatic intracranial hemorrhage. In
a univariate analysis, those with lower maximum sys-
tolic and diastolic BP levels 24 hours after the inter-
vention—163 6 20 vs 179 6 23 mm Hg systolic,
and 90 6 15 vs 97 6 14 mm Hg diastolic—had
greater likelihood of 3-month functional indepen-
dence. Similarly, those with higher postprocedure
maximum systolic and diastolic BP levels had higher
mortality. Despite the perceived risk of reperfusion
injury after recanalization, there was no association
between maximum systolic and diastolic BP levels
and symptomatic intracranial hemorrhage. Mean
and minimum BP levels did not have an effect on
any of the outcomes. In multivariable analysis, an
increment of 10 mm Hg in maximum systolic BP
was independently associated with a lower likelihood
of functional independence and a higher mortality
rate at 3 months. Among the 140 patients with com-
plete reperfusion, those undergoing permissive hyper-
tension as a BP target had a higher 3-month mortality
rate and lower frequency of functional independence.
The moderate BP goal of ,160/90 mm Hg was
independently linked to lower mortality at 3 months
compared to permissive hypertension.
In contrast to the cited previous data suggesting
that higher BP levels are desirable during the MT pro-
cedure, the data presented by Goyal et al.9 suggest
that lower BP targets are desirable during the first
From the Department of Neurology (K.E.W.), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany; and Department of Neurology
(S.A.M.), Neuroscience Institute, Henry Ford Health System, Detroit, MI.
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
528 © 2017 American Academy of Neurology
ª 2017 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
24 hours after established reperfusion. Accounting for
the available data, given the choice of targeting sys-
tolic BP ,180, ,160, or ,140 mm Hg for the first
24 hours after a successful MT procedure, taking the
middle road with an order to maintain systolic BP
,160 mm Hg using a continuous infusion calcium
channel blocker such as nicardipine or clevidipine
seems a prudent default strategy until higher-quality
data are available.
The reader must understand that these data,
although provocative, are far from definitive and
may actually prove misleading. As a retrospective
analysis of prospectively collected data at a single
institution with its own standards and treatment pro-
tocols, the data have a substantial risk for confound-
ing due to treatment allocation bias: the possibility
that an unmeasured variable explained both the deci-
sion to select a higher BP target and the poor out-
comes that occurred. In this case, the relative extent
of incomplete downstream hypoperfusion on the
postthrombectomy angiogram is the most likely con-
founding variable. Full recanalization has consistently
demonstrated better outcomes after LVO.1 Similarly,
based on our experience, the most common rationale
for selecting a higher BP target after MT is the pres-
ence of persistent primary or distal vessel occlusion
with dependence on collaterals. Both subtle and overt
degrees of incomplete downstream microvascular re-
perfusion, not captured by the TICI scale by the
treating team, may lead to overrepresentation in the
permissive hypertension group. Only a prospective
randomized trial can truly resolve this issue and deter-
mine the optimal target BP after MT.
The mechanism of death among the 29% of pa-
tients treated with permissive hypertension who died
(compared to 0% and 8% in the intensive and mod-
erate BP target groups) needs clarification. Hemor-
rhagic transformation does not explain the excess
mortality: the intensive BP-lowering group had the
highest rate of hemorrhagic transformation and the
lowest zero mortality. We encourage the authors to
follow up on this in a secondary analysis.
These new data from Goyal et al. add helpful pre-
liminary information to a previously evidence-free
zone. Given the available data, treating severe hyper-
tension after MT with a target of maintaining SBP
,160 mm Hg seems prudent. This target may
require adjustment after accounting for the final
degree of downstream recanalization and quality of
collaterals, baseline BP, use of thrombolytic therapy,
and cardiac and renal function. Future research
focusing on assessment of autoregulation and the
effect of BP variability (as opposed to the mean value)
may help. Ultimately, however, a prospective, ran-
domized trial will need to determine the optimal
BP management strategy.
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